These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17405988)

  • 1. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
    Pritchard KI
    J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
    Valagussa P; Bonadonna G
    Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the benefit of adjuvant therapy in breast cancer?].
    Sauer H
    Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancers of the breast. First line chemotherapy for cancers of the breast].
    Mauriac L
    Bull Cancer Radiother; 1995; 82(2):158-67. PubMed ID: 7546886
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):516-25. PubMed ID: 17405996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [-Adjuvant systemic therapy of breast carcinoma-].
    Goldhirsch A; Castiglione-Gertsch M
    Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized Trial.
    Ferretti G; Felici A; Carlini P; Cognetti F
    J Natl Cancer Inst; 2007 Sep; 99(18):1416. PubMed ID: 17848675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adjuvant systemic therapy of breast carcinoma].
    Wickramanayake PD; Katay I; Josting A; Diehl V
    Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems with the progesterone receptor in practice?
    Jordan VC; Gelber RD
    J Clin Oncol; 2007 May; 25(15):1957-9. PubMed ID: 17452674
    [No Abstract]   [Full Text] [Related]  

  • 16. HER2 and response to paclitaxel in node-positive breast cancer.
    Mehta R
    N Engl J Med; 2008 Jan; 358(2):197-8; author reply 198. PubMed ID: 18193531
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of breast cancer in the older patient.
    Muss HB
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):14-6. PubMed ID: 7863346
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 19. Mastectomy followed by cytoreductive chemotherapy in locally advanced breast cancer.
    Pluzańska A; Berner J; Dowgier-Witczak I; Malecka E; Pawlowski R; Wrezel E; Jeziorski A; Kamińska A; Tenderenda M
    J Chemother; 1989 Jul; 1(4 Suppl):1186-8. PubMed ID: 16312827
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.